Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 2005, p. 1655-1668, Vol. 25, No. 5
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.5.1655-1668.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Medicine, Division of Biochemistry, University of Fribourg, Fribourg,1 Swiss Institute of Bioinformatics, Epalinges, Switzerland2
Received 25 July 2004/ Returned for modification 20 September 2004/ Accepted 29 November 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Lipases constitute a heterogeneous family of proteins with carboxyl esterase activity and are activated by a lipid-water interface (for reviews, see references 34 and 51). Crystallographic analysis revealed that lipases are remarkably similar in structure despite low overall sequence conservation. They belong to the alpha/beta hydrolase fold family of enzymes with diverse hydrolytic functions. Their catalytic domain consist of a predominantly parallel beta-sheet structure of eight beta sheets connected by helical loops of various lengths that contain the catalytic-triad residues serine, aspartic acid, and histidine (10, 37, 42). The nucleophilic serine of this triad is itself part of the nearly ubiquitous lipase consensus sequence motif GXSXG (17). These three amino acids, assisted by the dipolar oxyanion hole, which stabilizes the charge distribution of the transition state, catalyze the hydrolysis of the ester bond (37).
Only a few gene products with lipolytic activity against neutral lipids have been characterized in Saccharomyces cerevisiae. Tgl1 has been proposed to be a triglyceride-specific lipase on the basis of its homology to lipases from humans and rats, but enzymatic activity of Tgl1 against triacylglycerol has never been demonstrated (1). TGL2, on the other hand, was found to prevent lethal accumulation of diacylglycerol (DAG) in a DAG kinase mutant Escherichia coli strain grown on arbutin, an artificial phosphoglycerol acceptor (49). Tgl2p displays sequence homology to Pseudomonas triacylglycerol lipases, and its expression in E. coli confers lipolytic activity against triacylglycerol and DAG with short-chain fatty acids (49). The physiological function of TGL2 in yeast, however, has not been characterized. A third lipase, Tgl3p, is required for mobilization of triacylglycerol in vivo, and the protein confers triacylglycerol lipase activity in vitro (7).
The gene(s) encoding steryl esterase(s) in yeast has not been identified. The steryl ester-hydrolyzing activity is induced under anaerobic conditions and enriched in the membrane pellet of semianaerobically grown yeast cells (46). The activity copurified with a 70-kDa protein, but the enzyme that catalyzes the reaction has not formally been identified (45).
The aim of this study was to identify the presumed steryl ester-hydrolyzing activity in yeast. The yeast genome contains three open reading frames (ORFs) that contain an alpha/beta hydrolase-associated lipase region, as classified by the pfam database of protein families. To determine whether one or more of these genes is required for steryl ester hydrolysis, we used an in vivo assay to monitor the mobilization of radiolabeled steryl ester in mutant strains lacking one, two, or all three of these candidate lipases. The results of this analysis indicate that together these three lipases account for all of the steryl ester-hydrolyzing activity that is present in yeast. Unexpectedly, all three yeast lipases appear to be membrane anchored, which makes them the first, to our knowledge, membrane-anchored neutral lipid lipases to be described. Their subcellular distribution and possible membrane topology with respect to the localization of the active site are discussed.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
|
Protein concentrations were determined by the method of Lowry et al. (33), with the Folin reagent and bovine serum albumin as the standard. Proteins were precipitated with 10% trichloroacetic acid (TCA), resuspended in sample buffer, and separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. Western blots were probed with rabbit antisera against GFP (1:5,000; Torrey Pines Biolabs, Inc., Houston, Tex.), Kar2 (1:5,000; M. Rose, Princeton University), Erg6 and porin (both 1:10,000; kind gifts from G. Daum, Graz University of Technology), Sed5p (1:3,000; a kind gift from H. Pelham, MRC Cambridge), Tlg1p (1:1,000; a kind gift from H. Pelham), Mnn1p (1:400, a kind gift from T. Graham, Vanderbilt University, Nashville, Tenn.), Pma1 (1:50,000), Gas1 (1:5,000, a kind gift from A. Conzelmann, University of Fribourg), or mouse anti-Pho8p (2 µg/ml; Molecular Probes).
Fractionation on an Accudenz density gradient was performed essentially as described by Cowles et al. (16). One hundred optical density (OD) units of exponentially growing cells were collected by centrifugation (3,000 x g, 10 min), resuspended in 100 mM Tris (pH 9.4)-10 mM dithiothreitol, and incubated for 10 min at 30°C. Cells were pelleted (3,000 x g, 5 min) and resuspended in 0.2x YPD medium-0.6 M sorbitol-10 mM KPi, pH 7.5. Cells were converted to spheroplasts by incubation with 16 U of Zymolyase (Seikagaku Corporation, Tokyo, Japan) for 20 min at 30°C. Spheroplasts were pelleted (4,000 x g, 20 min), resuspended in lysis buffer A (0.2 M sorbitol-50 mM potassium acetate-20 mM HEPES [pH 6.8]-2 mM EDTA-0.2 mM phenylmethylsulfonyl fluoride [PMSF] supplemented with a protease inhibitor cocktail [Complete; Roche-Diagnostics, Rotkreuz, Switzerland]), and lysed with a Dounce homogenizer. The homogenate was layered on top of an 8 to 43% Accudenz gradient (Accurate Chemical and Scientific Corp.) prepared in nine steps in lysis buffer A as described by Cowles et al. (16). The gradient was then centrifuged in a swing-out rotor (Sorvall TH641; Kendro Laboratory Products, Asheville, N.C.) at 170,000 x g for 18 h at 4°C. Eleven fractions of equal volume were collected from the top of the gradient, proteins were precipitated, and the distribution of marker proteins was analyzed by Western blotting.
To determine the membrane association of the GFP-tagged lipases, exponentially growing cells were pelleted by centrifugation (3,000 x g, 10 min), resuspended in lysis buffer A, converted to spheroplasts, and lysed as described above. The homogenate was precleared by centrifugation at 500 x g for 10 min and then separated into pellet (P13) and supernatant (S13) fractions by centrifugation at 13,000 x g for 20 min. The S13 fraction was then further separated into a 30,000 x g pellet (P30) and supernatant (S30) by centrifugation at 30,000 x g for 30 min. The S30 was fractionated again by centrifugation at 100,000 x g for 30 min to obtain a 100,000 x g pellet (P100) and supernatant (cytosol). All centrifugation steps were performed at 4°C.
To determine the membrane association and topology of the GFP-tagged lipases, detergent and salt extractions and proteinase K protection experiments were performed essentially as previously described (47). Detergent and salt extractions of microsomal membranes (P13) were performed by incubating 50 µg of the microsomal fraction with either 1% Triton X-100, 7% SDS, 1 M NaCl, or 0.1 M Na2CO3 in lysis buffer A without protease inhibitors for 30 min on ice. Samples were then centrifuged at 13,000 x g for 30 min, and proteins from the pellet and supernatant fractions were analyzed by Western blotting. For the proteinase K protection experiment, microsomes (50 µg) were incubated with 9, 14, or 28 µg of proteinase K per ml for 30 min on ice. The reaction was stopped by addition of PMSF (5 mM), and proteins were precipitated with 10% TCA. The pellet was dissolved in sample buffer, heated to 95°C for 5 min, and subjected to SDS-polyacrylamide gel electrophoresis and Western blot analysis.
Vacuoles and lipid particles were isolated by flotation as previously described (29). Briefly, spheroplasts were resuspended in lysis buffer B (12% Ficoll, 10 mM MES-Tris [pH 6.9], 0.2 mM EDTA) and lysed with a Dounce homogenizer. The lysate was cleared by centrifugation at 5,000 x g for 5 min. The supernatant was placed at the bottom of an ultracentrifuge tube and overlaid with lysis buffer. Lipid particles were subjected to flotation by centrifugation at 100,000 x g for 1 h. The floating fraction was removed, diluted with lysis buffer, and placed at the bottom of a second ultracentrifuge tube. The sample was overlaid with 8% Ficoll-10 mM MES-Tris (pH 6.9)-0.2 mM EDTA and centrifuged again at 100,000 x g for 1 h. The second flotation product was removed and diluted with 0.6 M sorbitol-8% Ficoll-10 mM MES-Tris (pH 6.9)-0.2 mM EDTA. The sample was then placed at the bottom of a third ultracentrifuge tube filled with 0.25 M sorbitol-10 mM MES-Tris (pH 6.9)-0.2 mM EDTA and again subjected to flotation by centrifugation at 100,000 x g for 1 h. The third flotation product was greatly enriched in lipid particle markers, whereas the pellet was enriched in vacuolar marker proteins.
Plasma membrane was enriched by centrifugation through a sucrose step gradient as previously described (43). Cells were harvested, resuspended in lysis buffer D (20 mM Tris [pH 8.5], 5 mM EDTA, 1 mM PMSF), and broken by vigorous agitation with 0.3-mm-diameter glass beads with a Merkenschlager homogenizer (B. Braun Biotech, Melsungen, Germany) equipped with CO2 cooling. The lysate was cleared by centrifugation (5,000 x g, 10 min), and membranes were pelleted by centrifugation (20,000 x g 10 min). Membranes were resuspended in TEDG (10 mM Tris HCl [pH 7.5], 1 mM EDTA, 20% glycerol, 0.2 mM dithiothreitol) and layered on top of a sucrose step gradient (53 to 43%, prepared in TEDG). This gradient was centrifuged at 120,000 x g for 2 h, and the membranes from the interface were collected with a syringe. The plasma membrane fraction was diluted in 10 mM Tris-1 mM EDTA and finally pelleted by centrifugation (20,000 x g, 20 min).
Fluorescence microscopy. In vivo localization of GFP-tagged versions of Yeh1, Yeh2, and Tgl1 was performed by fluorescence microscopy with a Zeiss Axioplan 2 (Carl Zeiss, Oberkochen, Germany) equipped with an AxioCam charge-coupled device camera and AxioVision 3.1 software. Lipid droplets were visualized with red fluorescent protein (RFP)-tagged Erg6 as a marker protein (24), and nuclei were visualized by 4',6'-diamidino-2-phenylindole (DAPI) staining.
In vivo neutral lipid mobilization. The neutral lipid pool was labeled by incubating the cells with 10 µCi of [3H]palmitic acid (American Radiolabeled Chemicals Inc., St. Louis, Mo.) per ml for 16 h at 24°C. Cells were then washed and diluted in liquid YPD medium containing either 10 µg of cerulenin (ICN Biomedicals, Irvine, Calif.) per ml or 30 µg of terbinafine (a kind gift from N. Ryder [Novartis Research Institute, Vienna, Austria]) per ml. Aliquots of cells were removed at the time points indicated. Cells were frozen and broken with glass beads, and lipids were extracted with chloroform-methanol (1:1, vol/vol). Radioactivity in the lipid extract was determined by scintillation counting, and equal counts were brought to dryness. Lipids were separated on thin-layer chromatography (TLC) plates (Merck, Darmstadt, Germany) developed in petroleum ether-diethyl ether-acetic acid (70:30:2, vol/vol) and quantified by scanning with a Berthold Tracemaster 40 Automatic TLC-Linear Analyzer. TLC plates were then exposed to a tritium-sensitive screen and visualized with a phosphorimager (Bio-Rad Laboratories, Hercules, Calif.).
Overexpression and quantification of the endogenous steryl ester pool.
The strains indicated were cultivated in rich medium containing either glucose (repressing conditions) or galactose (inducing conditions) as a carbon source. The neutral lipid pool was labeled to steady-state levels by incubating the cells with 10 µCi of [3H]palmitic acid (American Radiolabeled Chemicals Inc.) per ml for 16 h at 24°C. Cells were diluted in YPD or YPGal (1% Bacto Yeast Extract, 2% Bacto Peptone [U.S. Biological], 2% galactose) liquid medium containing terbinafine (30 µg/ml). Aliquots of cells were removed at the time points indicated, and 3 OD units were used for Western blot analysis. The remaining cells (
20 OD units) were washed and broken, and lipids were extracted as described above. Equal counts were brought to dryness, and lipids were separated on TLC plates, developed in petroleum ether-diethyl ether-acetic acid (70:30:2, vol/vol), and quantified by scanning with a Berthold Tracemaster 40 Automatic TLC-Linear Analyzer.
In vitro assay for steryl ester hydrolase activity. Overnight cultures of strains were broken with glass beads, and the membrane pellet was solubilized with 1% Triton X-100 in 50 mM Tris (pH 7.0)-10% glycerol-1 mM MnCl2 for 60 min at 4°C. Steryl ester hydrolase activity was determined with 100 to 300 µg of solubilized protein and cholesterol-[1-14C]oleate (specific activity, 50 to 60 mCi/mmol; American Radiolabeled Chemicals Inc.) as the substrate as previously described (46). The assay was performed at 30°C for 60 min in a reaction mixture containing 100 mM phosphate buffer (pH 6.9)-0.3% Triton X-100-26 nmol substrate. The reaction was stopped by addition of chloroform-methanol (1:2; vol/vol), lipids were extracted and separated by TLC with petroleum ether-diethyl ether-acetic acid (70:30:2, vol/vol) as a solvent system, and liberated fatty acids were quantified by scanning with a Berthold Tracemaster 40 Automatic TLC-Linear Analyzer. TLC plates were then visualized with a phosphorimager (Bio-Rad Laboratories).
| RESULTS |
|---|
|
|
|---|
|
mutant cells but not completely abolished, indicating the presence of additional, redundant, activities. To test whether YEH2 and/or TGL1 contribute to the residual steryl ester-hydrolyzing activity observed in yeh1
mutant cells, double- and triple-mutant strains were generated and tested for steryl ester hydrolysis in vivo. This analysis revealed that steryl ester hydrolysis is substantially reduced in any one of the three double mutants and completely blocked in a yeh1
yeh2
tgl1
triple mutant (Fig. 2). Interestingly, steryl ester levels steadily increased in the triple mutant, indicating that steryl ester synthesis is ongoing while their mobilization is completely blocked. These results indicate that all of the members of this lipase family contribute to steryl ester hydrolysis in vivo and that the lack of all three lipases cannot be compensated for by other activities. The observation that the triple-mutant strain grows like wild-type cells furthermore indicates that steryl ester hydrolysis is a nonessential process under standard growth conditions (data not shown).
|
|
|
|
|
To confirm the localization of Yeh1-GFP to lipid particles, lipid particles and associated vacuoles were isolated by subcellular fractionation and the degree of enrichment of Yeh1-GFP in these fractions was determined by Western blot analysis. Consistent with its microscopic localization, Yeh1-GFP is
11-fold enriched in the lipid particle fraction but hardly detectable in the vacuolar fraction (Fig. 5D). The second anti-GFP-reactive band, which migrates faster than the major
93-kDa band, is likely due to N-terminal degradation of Yeh1-GFP. This lipid particle fraction is highly enriched in its marker protein, Erg6 (
350-fold). We did not attempt to localize Tgl1 by fractionation because it is known to be a major lipid particle protein (8).
Since C-terminally GFP-tagged Yeh2 could not be localized by microscopy, its fractionation properties on an Accudenz density gradient were examined. Western blot analysis of Yeh2-GFP yields two major bands of
91 and
81 kDa, which appear to be due to some as yet unidentified modification of the protein. These two major and probably mature forms of Yeh2-GFP (Fig. 5C) were enriched in fractions 2 and 3 of the Accudenz gradient. The same fractions were also enriched for the plasma membrane proton-pumping ATPase Pma1 (Fig. 5E). Thus, fractionation of Yeh2-GFP expressed from its endogenous promoter is consistent with plasma membrane localization.
To further confirm the localization of Yeh2, plasma membrane from a strain expressing Yeh2-GFP was enriched by fractionation and the relative enrichment of Yeh2-GFP was determined by Western blot analysis. Similar to the glycosylphosphatidylinositol (GPI)-anchored plasma membrane protein Gas1, Yeh2 is enriched about sixfold in the plasma membrane fraction, consistent with plasma membrane localization of Yeh2. Other marker proteins, such as the mitochondrial porin or ER luminal Kar2 or Erg6, however, were not enriched in this fraction (Fig. 5F). These data indicate that all three lipases are membrane associated, that Yeh1 and Tgl1 localize to lipid particles, and that Yeh2 is enriched at the plasma membrane.
A lipase triple mutant has no detectable steryl ester hydrolase activity in vitro. To examine the contribution of the three lipases to steryl ester hydrolysis in vitro, we first determined whether the activity is present in a soluble or membrane-associated form. Therefore, wild-type cells were broken and the homogenate was separated into a soluble fraction and a membrane pellet. Membrane proteins were solubilized with 1% Triton X-100, and the steryl ester hydrolase activity in these fractions was determined by an in vitro assay with cholesterol-[1-14C]oleate as the substrate (46). This analysis revealed that the steryl ester-hydrolyzing activity was detectable in the membrane fraction only, which is consistent with the localization of their tagged versions.
We next determined the steryl ester hydrolase activity in the detergent-solubilized membrane fraction from lipase single-, double-, and triple-mutant cells. This analysis revealed that wild-type cells harbored the highest specific cholesteryl esterase activity whereas the triple mutant was devoid of any detectable activity. The activity present in the single and double mutants indicates that Yeh2 provides the main activity in this in vitro assay, as the activity was reduced to nondetectable levels in strains that lack YEH2 (Fig. 6A).
|
24-fold enriched in the lipid particle fraction from wild-type cells. Analyses of the lipid particle-associated activity from the yeh1
and tgl1
single-mutant and yeh1
tgl1
double-mutant strains indicate that the detectable activity depends on Tgl1. The in vitro assay hence monitors the activity of Yeh2 and Tgl1 but does not detect any Yeh1-dependent esterase activity (Fig. 6B).
To determine whether the Yeh2-dependent activity is indeed enriched in the plasma membrane, as predicted on the basis of its localization, the cholesteryl esterase activity in plasma membranes from wild-type and yeh2
mutant cells was determined. Consistent with its localization and its high relative contribution to the total cellular activity, the Yeh2-specific activity was
10-fold enriched in the plasma membrane fraction and this activity was completely dependent on YEH2 (Fig. 6C). The results of these in vitro assays are thus consistent with the protein localization data. They also indicate that Yeh1 may require different conditions for its activity in vitro.
Overexpression of Yeh1, Yeh2, and Tgl1 confers steryl ester hydrolysis in vivo. To determine whether independent expression of one of the three lipases is sufficient to induce steryl ester mobilization in vivo, expression of these genes was placed under the control of an inducible GAL1 promoter in a double-mutant background, thus allowing us to monitor the activity of each one of the lipases in the absence of the other two. At the same time, the lipases were tagged at their N termini with GFP, allowing the detection of each of the lipases under repressing (glucose) or inducing (galactose) conditions. Western blot analysis revealed that the GFP-tagged lipases were strongly expressed in cells grown in galactose-containing medium, but the tagged lipases were nondetectable when cells were grown in glucose-containing medium (Fig. 7A). Examination of the steryl ester pool in the lipase-expressing cells revealed that constitutive expression of each of the three lipases is sufficient to lower the steryl ester pool compared to that in a lipase triple-mutant strain (Fig. 7B). Cells cultivated in glucose, on the other hand, accumulated higher levels of steryl esters than did a corresponding wild-type strain. Levels of triacylglycerols, the second major neutral lipid, however, remained unaffected under these conditions (Fig. 7C). These data thus indicate that the N-terminally GFP-tagged versions of the three lipases are functional and that expression of each one of the three lipases is sufficient to induce mobilization of steryl esters in vivo.
|
|
To determine the accessibility of the C terminus of Yeh2, enriched plasma membrane vesicles from Yeh2-GFP-expressing cells were incubated with proteinase K. This resulted in the rapid appearance of a faster-migrating cleavage product that appeared to be the result of the removal of an
17-kDa fragment from the N-terminal domain of Yeh2-GFP. Blotting of these membranes with an antibody against the GPI-anchored protein Gas1 revealed that Gas1 was protease protected, indicating that the enriched plasma membrane mainly consisted of inside-out vesicles and hence that the protected C terminus of Yeh2 is likely localized in a luminal-extracellular compartment.
To further refine this topological characterization, the accessibility of the N termini of the three lipases to protease was examined. Therefore, the lipases were tagged with GFP at their N termini and their expression was placed under the control of the GAL1 promoter. Microscopic examination of cells expressing the N-terminally GFP-tagged lipases after overnight growth in galactose-containing medium revealed lipid particle staining for both GFP-Yeh1 and GFP-Tgl1 and plasma membrane staining for GFP-Yeh2 (data not shown). Proteinase accessibility of the N-terminal GFP was determined with the 13,000 x g membrane pellet from GFP-Yeh1- and GFP-Tgl1-expressing cells. These analyses revealed that the N-terminal epitope of Yeh1 was rapidly removed by the protease (Fig. 8C). Protease cleavage of GFP-Tgl1, on the other hand, resulted in the rapid appearance of a faster-migrating product, indicating that the N terminus of GFP-Tgl1 is protected but that its C terminus is cleaved to release a fragment of
12 kDa. Accessibility of the N terminus of Yeh2 was assessed again with enriched plasma membrane vesicles. Incubation of the plasma membrane from GFP-Yeh2-expressing cells with protease resulted in rapid disappearance of GFP-Yeh2, indicating that the N terminus of Yeh2 is cytosolic.
To determine whether the potential N-glycosylation sites of the three lipases are accessible for ER luminal glycosylation, the C-terminally GFP-tagged versions of these proteins were subjected to treatment with endoglycosidase H and their electrophoretic mobility was compared with that of nontreated controls. The results of this analysis did not reveal any difference between treated and untreated samples, indicating that these proteins are not N-glycosylated and hence that the corresponding asparagine residues are not exposed to the ER lumen. Probing the same Western membranes with an antibody against a protein known to be N-glycosylated, Gpi8, indicated that the endoglycosidase H treatment was successful (data not shown).
Taken together, these results indicate that Yeh1 is a membrane protein that localizes to intracellular lipid particles with both N and C termini exposed to the cytosol, which suggests that the protein is anchored in the membrane by at least two transmembrane domains. Because lipases contain an alpha/beta hydrolase fold, whereas known integral membrane proteins contain either alpha-helical or beta-barrel structures in their membrane-embedded domain, we propose that Yeh1 has a hairpin-like transmembrane domain in its N-terminal region that anchors the protein to the membrane. This would allow both termini of Yeh1 to face the same compartment and would allow proper folding of the lipase domain. A hairpin-like membrane anchor is supported by the fact that one of the algorithms used to predict transmembrane regions, Phobius, indicates that the N terminus of Yeh1 has a particularly long hydrophobic stretch encompassing amino acids 12 to 36 (Table 3). A similar hairpin-like topology has been suggested for caveolin (18); in this case, Phobius predicts a membrane anchor of 23 amino acids, which is close to the 24 residues predicted for Yeh1.
Tgl1, which also localizes to lipid particles, has its C terminus exposed to the cytosol and the N terminus protected in a lumen compartment. Such a topology could be due to either one or three transmembrane domains. As the topology with three transmembrane domains would place the hydrolase domain into a transmembrane segment, we propose a type I topology for Tgl1 as the more plausible alternative. Yeh2 also has its N and C termini at different sites of the membrane, compatible with either one or three transmembrane domains. On the basis of the same arguments, we propose the simpler type II topology for Yeh2. A schematic overview of the proposed membrane topology of the three proteins is shown in Fig. 9. All three topologies are compatible with a potential alpha/beta hydrolase fold of the respective lipase.
|
| DISCUSSION |
|---|
|
|
|---|
The three lipases encoded by YEH1, YEH2, and TGL1 constitute the yeast paralogues of the mammalian acid lipase family, which includes lysosomal acid lipase A (LIPA), the enteric gastric/lingual lipase LIPF, and four novel members that are predicted on the basis of the human genome sequence, LIPL1 to LIPL4 (3, 5). The lysosomal acid lipase is a key enzyme in the intracellular degradation of neutral lipids that have been internalized through receptor-mediated endocytosis of lipoprotein particles (19). The enzyme hydrolyzes cholesteryl esters and triacylglycerols, releasing free cholesterol and fatty acids. The released cholesterol rapidly equilibrates with the cellular pool to regulate its endogenous synthesis, esterification, and receptor-mediated uptake (11). Feedback regulation of sterol synthesis by the steryl ester pool in yeast is poorly characterized, but the lipase mutants now provide an important tool to address this pathway genetically. LIPA is active toward both steryl esters and triacylglycerols (5); the yeast enzymes, on the other hand, appear to be more specific for steryl esters, as triacylglycerol mobilization in vivo is not affected in triple-mutant cells.
LIPA deficiency in humans causes two rare autosomal recessive disorders, Wolman disease and cholesterol ester storage disease (4, 6, 13, 41). Wolman disease is lethal within the first year of life because of hepatosplenomegaly, adrenal calcification, and massive accumulation of triglycerides and cholesteryl esters in these organs, as well as in macrophages and blood vessels. Cholesterol ester storage disease is a less severe disorder with longer survival, hepatomegaly, premature atherosclerosis, and dyslipoproteinemias. Patients with the milder form of this lipid storage disease retain some residual LIPA activity (39). The crucial role of LIPA in steryl ester metabolism also prompted its consideration as an important factor in atherogenesis (6).
LIPA localizes to endosomes, where it cleaves low-density-lipoprotein-derived substrates. Our subcellular localization of GFP-tagged versions of the three yeast lipases indicates that Yeh1 and Tgl1 both localize to lipid particles whereas Yeh2 is enriched in the plasma membrane. Lipid particle localization of two of the three yeast steryl ester hydrolases, Yeh1 and Tgl1, is likely to allow regulated access to their neutral lipid substrates, which are stored in these particles (29). Intriguingly, however, both lipases appear to be membrane proteins on the basis of the detergent requirement for their solubilization. Yeh1 and Tgl1 are each proposed to be an integral membrane protein with an N-terminal transmembrane segment(s). This membrane anchoring is particularly remarkable in light of the fact that the lipid particle membrane has been proposed to be a monolayer rather than a normal bilayer membrane (29). It would thus be interesting to examine how these transmembrane domains can be accommodated in a lipid monolayer. Alternatively, it might be conceivable that the two lipases localize to domains of the lipid particle membrane that retain a bilayer rather than a monolayer structure.
The role of Yeh2 in light of its plasma membrane localization is less obvious than that of lipid particle-localized Yeh1 and Tgl1. But given the fact that the active site of the enzyme is located in a luminal-extracellular compartment, it is tempting to speculate that Yeh2 may be important to cleave either extracellular or endocytosed steryl esters. While yeast readily takes up exogenous fatty acids, sterols are taken up only under anaerobic conditions (32). The observation that Yeh2 alone in a yeh1
tgl1
double mutant does not efficiently mobilize steryl esters in vivo is consistent with a limiting access of the enzyme to the intracellular steryl ester pool, as predicted on the basis of the localization and topology of the enzyme. It is interesting that Yeh2 binds phosphatidylinositol-4,5-bisphosphate and phosphatidylinositol-3,4,5-triphosphate in vitro (54). While phosphatidylinositol-3,4,5-triphosphate has not been detected in S. cerevisiae (35, 36), it remains to be seen whether these signaling lipids affect the activity of the enzyme. The size variants of Yeh2 detected on Western blots are likely to be due to O-linked glycosylation of the luminal domain of Yeh2, which would be consistent with the proposed type II topology of the enzyme.
Levels of steryl esters are coordinated with the growth phase (9, 48). It is thus necessary that their synthesis, mobilization, or both processes are tightly regulated. An interesting question for further studies will thus be to examine whether and, if so, how the lipases obtain regulated access to their substrates and to further investigate the molecular mechanism of this regulation. Mobilization of steryl esters from lipid particles requires energy and ongoing protein synthesis but is independent of microtubules (28). Recent results obtained with mammalian cells suggest that an interplay between components that localize to the lipid droplets, such as perilipin and the lipase, in this case HSL, is important to coordinate substrate access. This interplay is regulated by protein kinase A to increase the rate of lipolysis by 30- to 100-fold (44). Even though yeast lipid particles lack any obvious perilipin orthologue, it is interesting that both Yeh1 and Tgl1, but not Yeh2, contain potential cyclic-AMP-dependent protein kinase A phosphorylation sites. Taken together, the identification and topological characterization of three yeast lipases now provide the opportunity to use S. cerevisiae to further characterize the molecular mechanisms that control sterol homeostasis at the cellular level.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Austrian Science Foundation, the Novartis Stiftung für Medizinisch-Biologische Forschung (02C62), and the Swiss National Science Foundation (631-065925).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Alani, E., L. Cao, and N. Kleckner. 1987. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116:541-545.
3. Ameis, D., M. Merkel, C. Eckerskorn, and H. Greten. 1994. Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. Eur. J. Biochem. 219:905-914.[Medline]
4. Anderson, R. A., R. S. Byrum, P. M. Coates, and G. N. Sando. 1994. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc. Natl. Acad. Sci. USA 91:2718-2722.
5. Anderson, R. A., and G. N. Sando. 1991. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J. Biol. Chem. 266:22479-22484.
6. Assmann, G., and U. Seedorf. 1995. Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease, p. 2563-2587. In C. R. Scriver, A. L. Beaduet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, N.Y.
7. Athenstaedt, K., and G. Daum. 2003. YMR313c/TGL3 encodes a novel triacylglycerol lipase located in lipid particles of Saccharomyces cerevisiae. J. Biol. Chem. 278:23317-23323.
8. Athenstaedt, K., D. Zweytick, A. Jandrositz, S. D. Kohlwein, and G. Daum. 1999. Identification and characterization of major lipid particle proteins of the yeast Saccharomyces cerevisiae. J. Bacteriol. 181:6441-6448.
9. Bailey, R. B., and L. W. Parks. 1975. Yeast sterol esters and their relationship to the growth of yeast. J. Bacteriol. 124:606-612.
10. Brady, L., A. M. Brzozowski, Z. S. Derewenda, E. Dodson, G. Dodson, S. Tolley, J. P. Turkenburg, L. Christiansen, B. Huge-Jensen, L. Norskov, et al. 1990. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. Nature 343:767-770.[CrossRef][Medline]
11. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
12. Brown, M. S., Y. K. Ho, and J. L. Goldstein. 1980. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255:9344-9352.
13. Burke, J. A., and W. K. Schubert. 1972. Deficient activity of hepatic acid lipase in cholesterol ester storage disease. Science 176:309-310.
14. Chang, T. Y., C. C. Chang, and D. Cheng. 1997. Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66:613-638.[CrossRef][Medline]
15. Corsi, A. K., and R. Schekman. 1997. The lumenal domain of Sec63p stimulates the ATPase activity of BiP and mediates BiP recruitment to the translocon in Saccharomyces cerevisiae. J. Cell Biol. 137:1483-1493.
16. Cowles, C. R., G. Odorizzi, G. S. Payne, and S. D. Emr. 1997. The AP-3 adaptor complex is essential for cargo-selective transport to the yeast vacuole. Cell 91:109-118.[CrossRef][Medline]
17. Derewenda, Z. S., and U. Derewenda. 1991. Relationships among serine hydrolases: evidence for a common structural motif in triacylglyceride lipases and esterases. Biochem. Cell. Biol. 69:842-851.[Medline]
18. Dupree, P., R. G. Parton, G. Raposo, T. V. Kurzchalia, and K. Simons. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12:1597-1605.[Medline]
19. Goldstein, J. L., S. E. Dana, J. R. Faust, A. L. Beaudet, and M. S. Brown. 1975. Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J. Biol. Chem. 250:8487-8495.
20. Graham, T. R., and V. A. Krasnov. 1995. Sorting of yeast
1,3-mannosyltransferase is mediated by a lumenal domain interaction, and a transmembrane domain signal that can confer clathrin-dependent Golgi localization to a secreted protein. Mol. Biol. Cell 6:809-824.[Abstract]
21. Hardwick, K. G., and H. R. Pelham. 1992. SED5 encodes a 39-kD integral membrane protein required for vesicular transport between the ER and the Golgi complex. J. Cell Biol. 119:513-521.
22. Heim, R., D. C. Prasher, and R. Y. Tsien. 1994. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA 91:12501-12504.
23. Holthuis, J. C., B. J. Nichols, S. Dhruvakumar, and H. R. Pelham. 1998. Two syntaxin homologues in the TGN/endosomal system of yeast. EMBO J. 17:113-126.[CrossRef][Medline]
24. Huh, W. K., J. V. Falvo, L. C. Gerke, A. S. Carroll, R. W. Howson, J. S. Weissman, and E. K. O'Shea. 2003. Global analysis of protein localization in budding yeast. Nature 425:686-691.[CrossRef][Medline]
25. Ito, H., Y. Fukada, K. Murata, and A. Kimura. 1983. Transformation of intact cells with alkali cations. J. Bacteriol. 153:163-168.
26. Jandrositz, A., F. Turnowsky, and G. Hogenauer. 1991. The gene encoding squalene epoxidase from Saccharomyces cerevisiae: cloning and characterization. Gene 107:155-160.[CrossRef][Medline]
27. Lange, Y., M. H. Swaisgood, B. V. Ramos, and T. L. Steck. 1989. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J. Biol. Chem. 264:3786-3793.
28. Leber, R., E. Zinser, C. Hrastnik, F. Paltauf, and G. Daum. 1995. Export of steryl esters from lipid particles and release of free sterols in the yeast, Saccharomyces cerevisiae. Biochim. Biophys. Acta 1234:119-126.[Medline]
29. Leber, R., E. Zinser, G. Zellnig, F. Paltauf, and G. Daum. 1994. Characterization of lipid particles of the yeast, Saccharomyces cerevisiae. Yeast 10:1421-1428.[CrossRef][Medline]
30. Lohse, P., S. Chahrokh-Zadeh, and D. Seidel. 1997. Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: identification of the catalytically active serine, aspartic acid, and histidine residues. J. Lipid Res. 38:892-903.[Abstract]
31. Longtine, M. S., A. McKenzie III, D. J. Demarini, N. G. Shah, A. Wach, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14:953-961.[CrossRef][Medline]
32. Lorenz, R. T., R. J. Rodriguez, T. A. Lewis, and L. W. Parks. 1986. Characteristics of sterol uptake in Saccharomyces cerevisiae. J. Bacteriol. 167:981-985.
33. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
34. Miled, N., S. Canaan, L. Dupuis, A. Roussel, M. Riviere, F. Carriere, A. de Caro, C. Cambillau, and R. Verger. 2000. Digestive lipases: from three-dimensional structure to physiology. Biochimie 82:973-986.[Medline]
35. Mitra, P., Y. Zhang, L. E. Rameh, M. P. Ivshina, D. McCollum, J. J. Nunnari, G. M. Hendricks, M. L. Kerr, S. J. Field, L. C. Cantley, and A. H. Ross. 2004. A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast. J. Cell Biol. 166:205-211.
36. Odrorizzi, G., M. Babst, and S. D. Emr. 2000. Phosphoinositide signaling and the regulation of membrane trafficking in yeast. Trends Biochem. Sci. 25:229-235.[CrossRef][Medline]
37. Ollis, D. L., E. Cheah, M. Cygler, B. Dijkstra, F. Frolow, S. M. Franken, M. Harel, S. J. Remington, I. Silman, J. Schrag, et al. 1992. The alpha/beta hydrolase fold. Protein Eng. 5:197-211.
38. Omura, S. 1981. Cerulenin. Methods Enzymol. 72:520-532.[Medline]
39. Pagani, F., R. Pariyarath, R. Garcia, C. Stuani, A. B. Burlina, G. Ruotolo, M. Rabusin, and F. E. Baralle. 1998. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J. Lipid Res. 39:1382-1388.
40. Pagani, F., R. Pariyarath, C. Stuani, R. Garcia, and F. E. Baralle. 1997. Cysteine residues in human lysosomal acid lipase are involved in selective cholesteryl esterase activity. Biochem. J. 326:265-269.
41. Patrick, A. D., and B. D. Lake. 1969. Deficiency of an acid lipase in Wolman's disease. Nature 222:1067-1068.[CrossRef][Medline]
42. Schrag, J. D., and M. Cygler. 1997. Lipases and alpha/beta hydrolase fold. Methods Enzymol. 284:85-107.[Medline]
43. Serrano, R. 1988. H+-ATPase from plasma membranes of Saccharomyces cerevisiae and Avena sativa roots: purification and reconstitution. Methods Enzymol. 157:533-544.[Medline]
44. Sztalryd, C., G. Xu, H. Dorward, J. T. Tansey, J. A. Contreras, A. R. Kimmel, and C. Londos. 2003. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J. Cell Biol. 161:1093-1103.
45. Taketani, S., T. Nishino, and H. Katsuki. 1981. Purification and properties of sterol-ester hydrolase from Saccharomyces cerevisiae. J. Biochem. (Tokyo) 89:1667-1673.
46. Taketani, S., T. Osumi, and H. Katsuki. 1978. Characterization of sterol-ester hydrolase in Saccharomyces cerevisiae. Biochim. Biophys. Acta 525:87-92.[Medline]
47. Tatzer, V., G. Zellnig, S. D. Kohlwein, and R. Schneiter. 2002. Lipid-dependent subcellular relocalization of the acyl chain desaturase in yeast. Mol. Biol. Cell 13:4429-4442.
48. Taylor, F. R., and L. W. Parks. 1978. Metabolic interconversion of free sterols and steryl esters in Saccharomyces cerevisiae. J. Bacteriol. 136:531-537.
49. Van Heusden, G. P., M. Nebohacova, T. L. Overbeeke, and H. Y. Steensma. 1998. The Saccharomyces cerevisiae TGL2 gene encodes a protein with lipolytic activity and can complement an Escherichia coli diacylglycerol kinase disruptant. Yeast 14:225-232.[CrossRef][Medline]